{"brief_title": "Seasonal Affective Depression (SAD) Study", "brief_summary": "A placebo controlled study evaluating the effectiveness of medication in preventing winter depressive episodes in patients with a history of Seasonal Affective Disorder", "detailed_description": "A 7-Month Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300mg/day of Extended-release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects with a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up Phase", "condition": ["Seasonal Affective Disorder (SAD)"], "intervention_type": ["Drug"], "intervention_name": ["Extended-release Bupropion Hydrochloride"], "criteria": "Inclusion Criteria: - History of Major Depressive Disorder (MDD) with a seasonal pattern. Exclusion Criteria: - Current or past history of seizure disorder or brain injury. - History or current diagnosis of anorexia nervosa or bulimia. - Recurrent summer depression more frequently than winter depression. - Primary diagnosis of panic disorder, Obsessive Compulsive Disorder (OCD), Post-traumatic Stress Disorder(PTSD), acute distress disorder, bipolar II disorder or other psychotic disorders. - Initiated psychotherapy within the last 3 months.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Winter depression, winter blues, depression, seasonal depression, seasonal affective disorder", "mesh_term": ["Mood Disorders", "Seasonal Affective Disorder", "Bupropion"], "id": "NCT00069459"}